AU2001286171A1 - Human cDNAs and proteins and uses thereof - Google Patents

Human cDNAs and proteins and uses thereof

Info

Publication number
AU2001286171A1
AU2001286171A1 AU2001286171A AU2001286171A AU2001286171A1 AU 2001286171 A1 AU2001286171 A1 AU 2001286171A1 AU 2001286171 A AU2001286171 A AU 2001286171A AU 2001286171 A AU2001286171 A AU 2001286171A AU 2001286171 A1 AU2001286171 A1 AU 2001286171A1
Authority
AU
Australia
Prior art keywords
proteins
uses
human cdnas
cdnas
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001286171A
Other versions
AU2001286171B8 (en
AU2001286171B2 (en
Inventor
Stephane Bejanin
Hiroaki Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Serono Genetics Institute SA
Original Assignee
Serono Genetics Institute S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US29357401P priority Critical
Priority to US60/293,574 priority
Priority to US29869801P priority
Priority to US60/298,698 priority
Priority to US30227701P priority
Priority to US60/302,277 priority
Priority to US60/305,456 priority
Priority to US30545601P priority
Priority to PCT/IB2001/001715 priority patent/WO2002094864A2/en
Application filed by Serono Genetics Institute S.A. filed Critical Serono Genetics Institute S.A.
Publication of AU2001286171B8 publication Critical patent/AU2001286171B8/en
Publication of AU2001286171A1 publication Critical patent/AU2001286171A1/en
Assigned to SERONO GENETICS INSTITUTE S.A. reassignment SERONO GENETICS INSTITUTE S.A. Amend patent request/document other than specification (104) Assignors: GENSET S.A.
Application granted granted Critical
Publication of AU2001286171B2 publication Critical patent/AU2001286171B2/en
Application status is Ceased legal-status Critical
Anticipated expiration legal-status Critical

Links

AU2001286171A 2001-05-25 2001-08-06 Human CDNAs and proteins and uses thereof Ceased AU2001286171B2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US29357401P true 2001-05-25 2001-05-25
US60/293,574 2001-05-25
US29869801P true 2001-06-15 2001-06-15
US60/298,698 2001-06-15
US30227701P true 2001-06-29 2001-06-29
US60/302,277 2001-06-29
US30545601P true 2001-07-13 2001-07-13
US60/305,456 2001-07-13
PCT/IB2001/001715 WO2002094864A2 (en) 2001-05-25 2001-08-06 Human cdnas and proteins and uses thereof

Publications (3)

Publication Number Publication Date
AU2001286171B8 AU2001286171B8 (en) 2002-12-03
AU2001286171A1 true AU2001286171A1 (en) 2003-05-08
AU2001286171B2 AU2001286171B2 (en) 2008-01-10

Family

ID=27501598

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001286171A Ceased AU2001286171B2 (en) 2001-05-25 2001-08-06 Human CDNAs and proteins and uses thereof

Country Status (7)

Country Link
US (10) US7074901B2 (en)
EP (1) EP1390497A2 (en)
JP (1) JP2005508141A (en)
AU (1) AU2001286171B2 (en)
CA (1) CA2448253A1 (en)
IL (1) IL159015D0 (en)
WO (1) WO2002094864A2 (en)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1489097E (en) 1994-01-11 2012-01-04 Dyax Corp Inhibitors of human plasmin derived from kunitz domains and nucleic acids encoding the same
US7129061B1 (en) * 1996-08-07 2006-10-31 Biogen Idec Ma Inc. Tumor necrosis factor related ligand
US20030100723A1 (en) * 2000-07-26 2003-05-29 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7317075B2 (en) * 2000-07-20 2008-01-08 Genentech, Inc. PRO21384 polypeptides
US6494879B2 (en) * 1998-10-15 2002-12-17 Scimed Life Systems, Inc. Treating urinary retention
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US20160287708A9 (en) * 2000-03-15 2016-10-06 Orbusneich Medical, Inc. Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device
US20050271701A1 (en) * 2000-03-15 2005-12-08 Orbus Medical Technologies, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
DE10054055A1 (en) 2000-10-31 2002-05-23 Nmi Univ Tuebingen A process for the analysis of proteins
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
US20070015144A9 (en) * 2001-05-25 2007-01-18 Genset, S.A. Human cDNAs and proteins and uses thereof
US7270960B2 (en) * 2001-08-29 2007-09-18 Pacific Northwest Research Institute Diagnosis of ovarian carcinomas
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
AU2002338947B2 (en) * 2001-11-30 2007-09-13 Laboratoires Serono Sa Methods of increasing protein expression levels
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US20040049484A1 (en) * 2002-09-11 2004-03-11 Hamano Life Science Research Foundation Method and apparatus for separating and extracting information on physiological functions
US7527969B2 (en) * 2002-06-19 2009-05-05 Raven Biotechnologies, Inc. RAAG10 cell surface target and a family of antibodies recognizing that target
EP1581164A4 (en) 2002-12-13 2008-03-12 Mediomics Llc Compositions and methods for inhibiting tumor growth and metastasis
SI1599222T1 (en) * 2003-01-08 2009-08-31 Novartis Vaccines & Diagnostic Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant
ES2356910T3 (en) 2003-01-17 2011-04-14 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Constructions for inducible expression of small interfering RNA (arns) for the selected gene silencing.
AU2003284678B2 (en) * 2003-02-24 2006-02-23 Morinaga Milk Industry Co., Ltd. Interleukin 6 production inhibitor
EP1616184B2 (en) * 2003-03-27 2018-05-30 Children's Hospital Medical Center A method and kit for detecting the early onset of renal tubular cell injury
US7134459B2 (en) * 2003-06-12 2006-11-14 Symyx Technologies, Inc. Methods and apparatus for mixing powdered samples
WO2005019434A2 (en) 2003-08-26 2005-03-03 The Regents Of The University Of Colorado, A Body Corporate Serine protease inhibitors for treatment of bacterial infections
EP1519194A1 (en) * 2003-09-24 2005-03-30 F. Hoffmann-La Roche Ag Use of gfap for identification of intracerebral hemorrhage
CA2539445A1 (en) * 2003-09-30 2005-04-07 Snow Brand Milk Products Co., Ltd. Agent for promoting osteogenesis and/or inhibiting bone resorption
JP4979385B2 (en) 2003-11-12 2012-07-18 ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト Compositions and methods for modulation of tumor necrosis factor alpha
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US20050215507A1 (en) * 2004-03-04 2005-09-29 Massachusetts Institute Of Technology Therapeutic anti-cancer DNA
AU2004317548A1 (en) * 2004-03-25 2005-10-06 Centocor, Inc. Use of EMMPRIN antagonists for the treatment of diseases associated with excessive angiogenesis
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
EP1614755A1 (en) * 2004-07-07 2006-01-11 ARTEMIS Pharmaceuticals GmbH Target transgenesis of short hairpin RNA expression cassette using recombinase mediated cassette exchange
WO2006012627A2 (en) * 2004-07-23 2006-02-02 Acceleron Pharma Inc. Actrii receptor polypeptides, methods and compositions
IL163453D0 (en) * 2004-08-10 2009-02-11 Yeda Res & Dev Enzyme inhibitor in leukemia
US20060039949A1 (en) * 2004-08-20 2006-02-23 Nycz Jeffrey H Acetabular cup with controlled release of an osteoinductive formulation
US9145582B2 (en) * 2004-09-22 2015-09-29 The Trustees Of The University Of Pennsylvania Microarray techniques for nucleic acid expression analyses
EP1835926A4 (en) 2004-11-22 2009-04-01 Dyax Corp Plasmin-inhibitory therapies
EP1859277A4 (en) 2005-02-17 2010-03-17 Biogen Idec Inc Treating neurological disorders
AU2006244014B2 (en) 2005-05-10 2011-03-17 Biogen Ma Inc. Treating and evaluating inflammatory disorders
US20060265352A1 (en) * 2005-05-20 2006-11-23 International Business Machines Corporation Methods and apparatus for information integration in accordance with web services
CA2611002A1 (en) * 2005-06-07 2006-12-14 The Rockefeller University Stimulation of pancreatic .beta. cell proliferation
WO2007019522A2 (en) * 2005-08-04 2007-02-15 Carlos Lopez Reversal of adult onset disorders with granulocyte-colony stimulating factors
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
KR20160137665A (en) 2005-11-23 2016-11-30 악셀레론 파마 인코포레이티드 - activin-actra antagonists and uses for promoting bone growth
US20070212721A1 (en) * 2006-01-27 2007-09-13 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
US8273005B2 (en) * 2006-02-02 2012-09-25 Samy Abdou Treatment of pain, neurological dysfunction and neoplasms using radiation delivery catheters
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
WO2007120658A1 (en) 2006-04-10 2007-10-25 Trustees Of Boston University Melanoma biomarker and methods of uses
ES2365077T3 (en) * 2006-06-16 2011-09-21 Onco Therapy Science, Inc. Peptide antigen derived anticancer sparc and pharmaceutical composition comprising the same.
US20100284933A1 (en) * 2006-10-16 2010-11-11 Biogen Idec Ma Inc. Biomarkers of Multiple Sclerosis
CA2668800A1 (en) * 2006-11-08 2008-06-05 Macrogenics West, Inc. Tes7 and antibodies that bind thereto
AU2007334333B2 (en) * 2006-12-18 2013-05-30 Acceleron Pharma Inc. Activin-ActRII antagonists and uses for increasing red blood cell levels
US20100028332A1 (en) * 2006-12-18 2010-02-04 Acceleron Pharma Inc. Antagonists of actriib and uses for increasing red blood cell levels
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
CN101835485B (en) * 2007-02-01 2016-10-26 阿塞勒隆制药公司 -Actriia activin antagonists and in the treatment or prevention of breast cancer
TW201907946A (en) 2007-02-02 2019-03-01 美商艾瑟勒朗法瑪公司 ActRIIB variants derived from their use
EP2484372A1 (en) * 2007-02-09 2012-08-08 Acceleron Pharma, Inc. Activin-ActRIIa Antagonists and Uses for Promoting Bone Growth in Cancer Patients
JP5572284B2 (en) * 2007-02-27 2014-08-13 Jx日鉱日石エネルギー株式会社 Refrigerator oil and working fluid composition for refrigerator
US20080261298A1 (en) * 2007-04-23 2008-10-23 Olympus American Inc. Method and device for the multiplex analysis of cells and tissues
EP3366695A1 (en) 2009-12-17 2018-08-29 Children's Medical Center, Corp. Saposin-a derived peptides and uses thereof
CA2699936A1 (en) * 2007-09-18 2009-03-26 Acceleron Pharma Inc. Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
EP3381445A3 (en) * 2007-11-15 2019-01-16 Amgen Inc. Aqueous formulation of antibody stablised by antioxidants for parenteral administration
JO2913B1 (en) * 2008-02-20 2015-09-15 امجين إنك, Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
KR101871510B1 (en) * 2008-06-26 2018-06-26 악셀레론 파마 인코포레이티드 Methods for dosing an activin-actriia antagonist and monitoring of treated patients
WO2009158015A2 (en) * 2008-06-26 2009-12-30 Acceleron Pharma Inc. Antagonists of actriib and uses for increasing red blood cell levels
GB0813123D0 (en) * 2008-07-17 2008-08-27 Symbian Software Ltd Method of searching
US20100015645A1 (en) * 2008-07-18 2010-01-21 Kaohsiung Medical University Il-8 as biomarker for the detection of urolithiasis
WO2010011860A1 (en) 2008-07-23 2010-01-28 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes
DK2340031T3 (en) 2008-08-14 2019-07-15 Acceleron Pharma Inc Gdf customer for use of analysis treatment
US8216997B2 (en) * 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
AU2010204985A1 (en) 2009-01-13 2011-08-04 Acceleron Pharma Inc. Methods for increasing adiponectin
WO2010144452A1 (en) 2009-06-08 2010-12-16 Acceleron Pharma Inc. Methods for increasing thermogenic adipocytes
KR20180026795A (en) 2009-06-12 2018-03-13 악셀레론 파마 인코포레이티드 TRUNCATED ActRIIB-FC FUSION PROTEINS
EP2464661B1 (en) 2009-08-13 2018-01-17 The Johns Hopkins University Methods of modulating immune function with anti-b7-h7cr antibodies
US20110129469A1 (en) * 2009-11-03 2011-06-02 Acceleron Pharma Inc. Methods for treating fatty liver disease
WO2011063018A1 (en) 2009-11-17 2011-05-26 Acceleron Pharma Inc. Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
JP2013545439A (en) 2010-09-17 2013-12-26 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ Functional genomics assay to characterize the usefulness and safety of pluripotent stem cells
WO2012064771A1 (en) 2010-11-08 2012-05-18 Acceleron Pharma, Inc. Actriia binding agents and uses thereof
KR20140096257A (en) 2011-06-24 2014-08-05 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
KR20140147797A (en) 2011-06-27 2014-12-30 더 잭슨 래보라토리 Methods and compositions for treatment of cancer and autoimmune disease
WO2013055911A1 (en) 2011-10-14 2013-04-18 Dana-Farber Cancer Institute, Inc. Znf365/zfp365 biomarker predictive of anti-cancer response
CA2855640A1 (en) 2011-11-14 2013-05-23 The General Hospital Corporation Assays and methods for selecting a treatment regimen for a subject with depression
EP3492095A1 (en) 2012-04-01 2019-06-05 Technion Research & Development Foundation Limited Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies
US9564064B2 (en) 2012-04-16 2017-02-07 Eugenio Minvielle Conditioner with weight sensors for nutritional substances
US9528972B2 (en) 2012-04-16 2016-12-27 Eugenio Minvielle Dynamic recipe control
US9072317B2 (en) 2012-04-16 2015-07-07 Eugenio Minvielle Transformation system for nutritional substances
US20130269537A1 (en) 2012-04-16 2013-10-17 Eugenio Minvielle Conditioning system for nutritional substances
US9436170B2 (en) 2012-04-16 2016-09-06 Eugenio Minvielle Appliances with weight sensors for nutritional substances
US10219531B2 (en) 2012-04-16 2019-03-05 Iceberg Luxembourg S.A.R.L. Preservation system for nutritional substances
US9080997B2 (en) 2012-04-16 2015-07-14 Eugenio Minvielle Local storage and conditioning systems for nutritional substances
US9069340B2 (en) 2012-04-16 2015-06-30 Eugenio Minvielle Multi-conditioner control for conditioning nutritional substances
US20130269538A1 (en) 2012-04-16 2013-10-17 Eugenio Minvielle Transformation system for nutritional substances
US9541536B2 (en) 2012-04-16 2017-01-10 Eugenio Minvielle Preservation system for nutritional substances
US9429920B2 (en) 2012-04-16 2016-08-30 Eugenio Minvielle Instructions for conditioning nutritional substances
US9414623B2 (en) * 2012-04-16 2016-08-16 Eugenio Minvielle Transformation and dynamic identification system for nutritional substances
US9171061B2 (en) 2012-04-16 2015-10-27 Eugenio Minvielle Local storage and conditioning systems for nutritional substances
US9121840B2 (en) 2012-04-16 2015-09-01 Eugenio Minvielle Logistic transport system for nutritional substances
US8733631B2 (en) 2012-04-16 2014-05-27 Eugenio Minvielle Local storage and conditioning systems for nutritional substances
US20140069838A1 (en) 2012-04-16 2014-03-13 Eugenio Minvielle Nutritional Substance Label System For Adaptive Conditioning
US9702858B1 (en) 2012-04-16 2017-07-11 Iceberg Luxembourg S.A.R.L. Dynamic recipe control
US9460633B2 (en) 2012-04-16 2016-10-04 Eugenio Minvielle Conditioner with sensors for nutritional substances
RU2018145985A (en) 2012-11-02 2019-02-18 Селджин Корпорейшн Activin-actrii antagonists and their application for treatment of bone tissue disorders and other disorders
WO2014200905A2 (en) 2013-06-10 2014-12-18 President And Fellows Of Harvard College Early developmental genomic assay for characterizing pluripotent stem cell utility and safety
AU2015212341A1 (en) 2014-02-03 2016-09-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of Casein kinase I inhibitors for depleting stem cells
CN107135646A (en) 2014-06-13 2017-09-05 阿塞勒隆制药公司 Methods and compositions for treating ulcers
USD762081S1 (en) 2014-07-29 2016-07-26 Eugenio Minvielle Device for food preservation and preparation
KR101713421B1 (en) * 2015-07-03 2017-03-09 울산대학교 산학협력단 Composition for diagnosing or treating brain neuronal disease
IL247368D0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
WO2019094578A1 (en) 2017-11-09 2019-05-16 Alnylam Pharmaceuticals Inc. Assays and methods for determining expression of the lect2 gene

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) * 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4657760A (en) * 1979-03-20 1987-04-14 Ortho Pharmaceutical Corporation Methods and compositions using monoclonal antibody to human T cells
US4444887A (en) * 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4469863A (en) * 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
FI831484L (en) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen Activator Foer maenskovaevnad
US4716111A (en) * 1982-08-11 1987-12-29 Trustees Of Boston University Process for producing human antibodies
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US4609725A (en) * 1984-10-09 1986-09-02 Merck & Co., Inc. Cardiac atrial peptides
AU6131086A (en) * 1985-07-05 1987-01-30 Whitehead Institute For Biomedical Research Epithelial cells expressing foreign genetic material
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5340934A (en) * 1989-11-03 1994-08-23 The United States Of Americas As Represented By The Secretary Of Health & Human Services CDNA sequences of human bone matrix proteins
US5817629A (en) 1991-10-22 1998-10-06 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
GB9216558D0 (en) 1992-08-04 1992-09-16 British Bio Technology Modified proteases
US5744346A (en) 1995-06-07 1998-04-28 Athena Neurosciences, Inc. β-secretase
US6221645B1 (en) 1995-06-07 2001-04-24 Elan Pharmaceuticals, Inc. β-secretase antibody
WO1996040885A2 (en) 1995-06-07 1996-12-19 Athena Neurosciences, Inc. β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION
GB9701684D0 (en) 1997-01-28 1997-03-19 Smithkline Beecham Plc Novel compounds
WO1999014234A2 (en) * 1997-09-17 1999-03-25 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
US20060009633A9 (en) * 1997-11-13 2006-01-12 Genset, S.A. Complementary DNAs encoding proteins with signal peptides
EP1042725A1 (en) * 1997-12-16 2000-10-11 President And Fellows Of Harvard College Computer-generated mimetics with endostatin coordinates
DE69841110D1 (en) 1997-12-17 2009-10-08 Serono Genetics Inst Sa Extended cdns that encode secreted proteins
EP1060193A2 (en) 1998-03-03 2000-12-20 Abgenix, Inc. Cd147 binding molecules as therapeutics
AU764571B2 (en) * 1998-04-09 2003-08-21 Genset S.A. 5' ESTs and encoded human proteins
US6184241B1 (en) 1998-08-24 2001-02-06 Kansas State University Research Foundation Aspartic protease inhibitors
SG113454A1 (en) 1998-09-24 2005-08-29 Upjohn Co Alzheimer's disease secretase
WO2000035473A2 (en) * 1998-12-18 2000-06-22 Scios Inc. Methods for detection and use of differentially expressed genes in disease states
CN1390232A (en) 1999-02-10 2003-01-08 艾兰制药公司 Human beta-secretase enzyme, inhibitor, and its composition and use
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
WO2000058479A1 (en) 1999-03-26 2000-10-05 Amgen Inc. Beta secretase genes and polypeptides
DE19915485A1 (en) * 1999-04-07 2000-10-19 Hugo A Katus Treatment of heart failure
AU5773500A (en) 1999-06-28 2001-01-31 Board Of Trustees Of The University Of Illinois, The Inhibitors of memapsin 2 and use thereof
AU7058000A (en) * 1999-08-13 2001-03-13 Human Genome Sciences, Inc. 13 human colon and colon cancer associated proteins
AU5241100A (en) * 1999-09-28 2001-04-30 Universitat Zurich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
WO2001053455A2 (en) 1999-12-23 2001-07-26 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002000677A1 (en) * 2000-06-07 2002-01-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies

Similar Documents

Publication Publication Date Title
AU2002211665A1 (en) Human Ect2 and methods of use
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2001275445A1 (en) 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
AU2002332464A1 (en) Nutritional supplements and methods of using same
AU2002352903A1 (en) Mesoporous materials and methods
EP1435911A4 (en) Devices including protein matrix materials and methods of making and using same
AU2002337793A1 (en) Protein and peptide nanoarrays
EP1379132A4 (en) Human secreted proteins
AU2002248708A1 (en) Medical stent and related methods
AU2002322295A1 (en) Spherical protein particles and methods of making and using them
EP1192911A3 (en) Bone connecting tool and connecting member thereof
AU2002356953A1 (en) Anti-aging skin care composition and uses thereof
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
EP1572880A3 (en) Defensin polynucleotides and methods of use
AU2002322388A1 (en) Defensin polynucleotides and methods of use
AU2002307494A1 (en) Human timp-1 antibodies
HK1142272A1 (en) Specific binding proteins and uses thereof
AU2001298042A1 (en) Optimized pulsatile-flow ventricular-assist device and total artificial heart
AU2002229510A1 (en) Combined use of factor vii polypeptides and factor viii polypeptides
AU2002331621A1 (en) 2H-phthalazin-1-ones and methods for use thereof
AU2002240120A1 (en) Modified antibodies and methods of use
AU2001290784A1 (en) Antimicrobial peptides and methods of use
AU2002322436A1 (en) Antagonistic anti-HTNFSF13B human antibodies
AU2002337953A1 (en) Gentle-acting skin-disinfectants and hydroalcoholic gel formulations
AU2002319469A1 (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease